Related references
Note: Only part of the references are listed.PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
Xudong Zhang et al.
ADVANCED MATERIALS (2018)
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Shuangjiang Yu et al.
ADVANCED MATERIALS (2018)
Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
Alexander S. Cheung et al.
NATURE BIOTECHNOLOGY (2018)
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen Weiwei Li et al.
NATURE MATERIALS (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy
Chao Wang et al.
BIOCONJUGATE CHEMISTRY (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min et al.
NATURE NANOTECHNOLOGY (2017)
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Jianqin Lu et al.
NATURE COMMUNICATIONS (2017)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
Chao Wang et al.
NATURE BIOMEDICAL ENGINEERING (2017)
A melanin-mediated cancer immunotherapy patch
Yanqi Ye et al.
SCIENCE IMMUNOLOGY (2017)
Roles for Innate Immunity in Combination Immunotherapies
Kelly D. Moynihan et al.
CANCER RESEARCH (2017)
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Chao Wang et al.
ADVANCED MATERIALS (2017)
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
Yongkui Li et al.
ONCOIMMUNOLOGY (2016)
Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors
Yanqi Ye et al.
ACS NANO (2016)
Recent advances of cocktail chemotherapy by combination drug delivery systems
Quanyin Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy
Chao Liang et al.
CHEMICAL SOCIETY REVIEWS (2016)
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
Xiaopin Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy
Kuangda Lu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Chao Wang et al.
NANO LETTERS (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
Celine Boutros et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
Hok Hei Tam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Adapting Cancer Immunotherapy Models for the Real World
Lairyn E. Klevorn et al.
TRENDS IN IMMUNOLOGY (2016)
An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Yichao Chen et al.
NATURE COMMUNICATIONS (2016)
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
Chunbai He et al.
NATURE COMMUNICATIONS (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Enhanced Anti-Tumor Efficacy through a Combination of Integrin alpha v beta 6-Targeted Photodynamic Therapy and Immune Checkpoint Inhibition
Liquan Gao et al.
THERANOSTICS (2016)
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
Shu Su et al.
SCIENTIFIC REPORTS (2016)
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment
Luo Gu et al.
NATURE REVIEWS CANCER (2016)
Regulatory circuits of T cell function in cancer
Daniel E. Speiser et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy
Jian Xiang et al.
ACS NANO (2015)
Anticancer Platelet-Mimicking Nanovehicles
Quanyin Hu et al.
ADVANCED MATERIALS (2015)
Platelets at the interface of thrombosis, inflammation, and cancer
Aime T. Franco et al.
BLOOD (2015)
Radiotherapy Complements Immune Checkpoint Blockade
Shin Foong Ngiow et al.
CANCER CELL (2015)
Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges
Feifei Teng et al.
CANCER LETTERS (2015)
Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy
Michael S. Goldberg
CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nanoparticle biointerfacing by platelet membrane cloaking
Che-Ming J. Hu et al.
NATURE (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Big thinking for adjuvants
Eric L. Dane et al.
NATURE BIOTECHNOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Checkpoint blockade in combination with cancer vaccines
Michael A. Morse et al.
VACCINE (2015)
Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti-CTLA-4 Therapy to Inhibit Cancer Metastasis
Chao Wang et al.
ADVANCED MATERIALS (2014)
Emerging roles for platelets as immune and inflammatory cells
Craig N. Morrell et al.
BLOOD (2014)
Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors
Juan Fu et al.
CANCER RESEARCH (2014)
Functional Nanomaterials for Phototherapies of Cancer
Liang Cheng et al.
CHEMICAL REVIEWS (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma
Minghui Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2013)
Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
Yuhua Wang et al.
MOLECULAR THERAPY (2013)
Tumor metastasis: moving new biological insights into the clinic
Liling Wan et al.
NATURE MEDICINE (2013)
B7-H5 costimulates human T cells via CD28H
Yuwen Zhu et al.
NATURE COMMUNICATIONS (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Thomas J. Lynch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs
Adrian C. Begg et al.
NATURE REVIEWS CANCER (2011)
Contribution of platelets to tumour metastasis
Laurie J. Gay et al.
NATURE REVIEWS CANCER (2011)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Emily Gullotti et al.
MOLECULAR PHARMACEUTICS (2009)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu et al.
NATURE (2009)
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
Brian T. Fife et al.
IMMUNOLOGICAL REVIEWS (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: Role of IDO
Gargi D Basu et al.
JOURNAL OF IMMUNOLOGY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
IDO and tolerance to tumors
DH Munn et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Cancer vaccines: Between the idea and the reality
OJ Finn
NATURE REVIEWS IMMUNOLOGY (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
H Ueda et al.
NATURE (2003)
Targeted drug delivery via the folate receptor
J Sudimack et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Share Paper
